Stromal-vascular fraction content and adipose stem cell behavior are altered in morbid obese and post bariatric surgery ex-obese women by unknown
Silva et al. Stem Cell Research & Therapy  (2015) 6:72 
DOI 10.1186/s13287-015-0029-xRESEARCH Open AccessStromal-vascular fraction content and adipose
stem cell behavior are altered in morbid obese
and post bariatric surgery ex-obese women
Karina R Silva1,2,3*, Sally Liechocki4, João R Carneiro5, Cesar Claudio-da-Silva6, Clarissa M Maya-Monteiro4,
Radovan Borojevic1,3 and Leandra S Baptista1,2,3*Abstract
Introduction: Subcutaneous adipose tissue is an interesting source of autologous stem cells with a fundamental
role in the pathophysiology of obesity, metabolic syndromes and insulin resistance. We hypothesize that obesity
could alter the stromal-vascular fraction (SVF) and adipose stem cell (ASCs) functions, which could compromise its
regenerative behavior. Furthermore, we aimed to evaluate whether ASCs derived from post bariatric surgery ex-obese
women maintain their functions in a similar fashion as do those from individuals who have never been obese.
Methods: The SVF of subcutaneous adipose tissue from control (n = 6, body mass index – BMI - 27.5 ± 0.5 kg/m2),
obese (n = 12, BMI 46.2 ± 5.1 kg/m2) and post bariatric surgery ex-obese (n = 7, initial BMI 47.8 ± 1.3 kg/m2; final BMI
28.1 ± 1.1 kg/m2) women were isolated and evaluated by flow cytometry. ASCs were tested for lipid accumulation by
perilipin, adipose differentiation-related protein (ADRP) and Oil Red O staining after adipogenic stimulus. The cytokines
secreted by the ASCs and after lipid accumulation induction were also evaluated.
Results: The subcutaneous adipose tissue of obese and post bariatric surgery ex-obese women was enriched in
pericytes (p = 0.0345). The number of supra-adventitial cells was not altered in the obese patients, but it was highly
enriched in the post bariatric surgery ex-obese women (p = 0.0099). The ASCs of the post bariatric surgery ex-obese
patients secreted more MCP-1 (monocyte chemoattractant protein-1; p = 0.0078). After lipid accumulation induction,
the ASCs of the patients in all groups secreted less IL-6 than the ASCs with no adipogenic stimulus (p < 0.0001). Obese
ASCs with lipid accumulation secreted the highest amount of IL-6 (p < 0.001) whereas the ASCs from the controls
secreted the highest amount of adiponectin (p < 0.0001). The ASCs from the post bariatric surgery ex-obese patients
showed the highest levels of lipid accumulation whereas those from the obese women had the lowest levels (p < 0.0001).
Conclusions: SVF content and ASC behavior are altered in the subcutaneous adipose tissue of morbid obese
women; these changes are not completely restored after bariatric surgery-induced weight loss. The cellular
alterations described in this study could affect the regenerative effects of adipose stem cells. Further investigations are
required to avoid jeopardizing the development of autologous stem cell-based therapies.Introduction
Subcutaneous adipose tissue is an interesting source of au-
tologous stem cells for cell-based therapies because of its
accessibility, quantity and ease of harvest during aesthetic
lipoaspiration procedures [1]. In addition, multiple studies
have shown the beneficial effects of subcutaneous fat stem
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sue also has a fundamental role in the pathophysiology of
obesity, metabolic syndromes and insulin resistance be-
cause a secretory source of adipokines is involved in the
inflammatory scenario, such as leptin, adiponectin, inter-
leukin (IL)-6 and IL-8 [5]. Adipocytes and cells from the
stromal vascular fraction (SVF) contribute to the secretory
function of adipose tissue [6-8]. Although adipocytes are
the main source of hormones such as leptin and adiponec-
tin, inflammatory cytokines are mostly secreted by stromal
vascular cells [9,10].is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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cells, endothelial cells, fibroblasts and macrophages [11].
Within the adipose tissue, cells with regenerative po-
tential are identified as pericytes (CD45−CD146+CD34−
cells), which reside in small vessels, and supra-
adventitial cells (CD45−CD146−CD34+ cells), which
dwell in larger vessels with preadipocyte characteristics
[12]. SVF cells can be isolated by the enzymatic diges-
tion of adipose tissue and centrifugal separation. Once
placed into tissue culture, SVF cells are further sepa-
rated based on adherence to plastic and culture expan-
sion. Most of the remaining cells are pericytes and
supra-adventitial cells, which are now referred to as
adipose stem cells (ASCs) [13].
It is well documented that obesity induces an accumu-
lation of macrophages in the adipose SVF. These re-
cruited macrophages contribute to chronic inflammation
because of the production of proinflammatory mole-
cules, which is typical of M1 or classically activated mac-
rophages [9,14]. Infiltrated macrophages differ from
adipose tissue resident macrophages, called M2 macro-
phages, which are in an alternatively activated state with
anti-inflammatory characteristics [15,16]. Because complete
SVF transplant is considered an approach for therapeutic
purposes [17-19], it is important to evaluate whether obes-
ity modifies the composition of the progenitor compart-
ment of adipose SVF. Bariatric surgery is commonly used
for morbid obesity treatment and leads to massive weight
loss. After weight loss stabilization, postbariatric surgery ex-
obese patients present residual subcutaneous adipose tissue
whose physiology is not yet fully understood. Based on our
previous results showing a considerable alteration on the
subcutaneous adipose tissue vascular tree [20], we hypothe-
sized that massive weight loss is not enough to recover the
nonobese composition of the adipose SVF.
ASCs were found to have an anti-inflammatory effect
in vitro [21,22], and the paracrine effects of ASCs and
adipose SVF cells as regulators of immune tolerance
in vivo are being widely investigated, opening new thera-
peutic promise to treat autoimmune diseases [4,18,22-25].
The disruption of adipose tissue homeostasis and stress
conditions, as found in diabetes, alters ASC function
[26-28], and the treatment of multiple sclerosis with au-
tologous murine ASCs showed no improvement on the
disease progression [29]. Therefore, we also hypothesize
that the inflammatory scenario established during obesity
could alter ASC function in terms of inflammatory cyto-
kine secretion, which could compromise its regenerative
behavior. Furthermore, it is important to know whether
ASCs derived from postbariatric surgery ex-obese women
maintain their functions similarly to those from individ-
uals who have never been obese.
To achieve this goal, the SVF of human abdominal
subcutaneous adipose tissue from control, obese andpostbariatric surgery ex-obese patients were isolated to
evaluate the distribution of the SVF cell populations of
subcutaneous adipose tissue and to obtain and
characterize ASCs, focusing on functional assays – adi-
pokine secretion and the capacity to accumulate lipids.
This study will help to guide the proper use of stem cells
derived from obese and postbariatric surgery ex-obese
patients for autologous cellular therapy approaches in
regenerative medicine. In addition, this study could in-
crease our understanding of how ASCs participate in the
development of obesity and their behavior after weight
loss induced by bariatric surgery.
This study addresses the following hypotheses: massive
weight loss is not sufficient to recover the nonobese
composition of the adipose SVF; the inflammatory sce-
nario established during obesity could alter ASC func-
tions in terms of inflammatory cytokine secretions,
which could compromise its regenerative behavior; and
ASCs derived from postbariatric surgery ex-obese pa-
tients could be different to those from individuals who
have never been obese.
Methods
Patients and tissue harvesting
Abdominal subcutaneous adipose tissue fragments were
obtained from nondiabetic female obese patients, post-
bariatric surgery ex-obese patients and control patients.
The obese group included patients with morbid obesity,
with a body mass index (BMI) >40 kg/m2 (n = 12, age =
37.3 ± 13.4 years, BMI = 46.2 ± 5.1 kg/m2). Three of the
patients presented systemic arterial hypertension. A
small fragment of the subcutaneous adipose tissue from
these patients was excised during bariatric surgery. The
bariatric surgery-induced weight loss patients or the
postbariatric surgery ex-obese patients who were in-
cluded in this study had lost weight during the 2 to 4
years following bariatric surgery, reaching a BMI between
25.0 and 29.9 kg/m2 (n = 7, age = 45 ± 8.3 years, initial
BMI = 47.8 ± 1.3 kg/m2; final BMI = 28.1 ± 1.1 kg/m2). Be-
cause residual subcutaneous adipose tissue remained after
the surgery, resulting in flaccid skin due to major weight
loss, these patients underwent abdominal plastic surgery,
in which a fragment of the subcutaneous adipose tissue
was excised. Although the studied tissues of the obese and
postbariatric surgery ex-obese patients were not paired
samples (presurgery and postsurgery samples), they all
followed the same Morbid Obesity Program of the
Clementino Fraga Filho University Hospital. All of the
obese and postbariatric surgery ex-obese patients were
nondiabetic females and had similar BMI values when
they had morbid obesity. Nondiabetic patients without
previous history of morbid obesity and with a BMI be-
tween 25.0 and 29.9 kg/m2 (n = 6, age = 47.2 ± 11.0
years, BMI = 27.5 ± 0.5 kg/m2) were included as a
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ous adipose tissue excised during abdominal plastic sur-
gery performed for aesthetic purposes. This study was
approved by the Research Ethics Committee of the
Clementino Fraga Filho University Hospital, Federal
University of Rio de Janeiro, Brazil (Protocols 145/09
and 076/10), and informed consent was obtained from
all individual participants included in the study.
Isolation of stromal vascular fraction and adipose stem
cell culture
Subcutaneous adipose tissue fragments from obese pa-
tients, postbariatric surgery ex-obese patients and con-
trol patients were cut into small pieces and incubated
with 1 mg/ml collagenase type II (Sigma Chemical, St.
Louis, MO, USA) in a shaking water bath at 37°C for 40
minutes. The mature adipocytes were eliminated by cen-
trifugation (400 × g, room temperature, 15 minutes), and
the pellet was resuspended for clearing the tissue resi-
dues on 100 μm strainers. After counting, the cells were
separated for flow cytometry analyses of stromal vascular
cells or plated to expand in vitro ASCs in tissue culture
flasks with low-glucose Dulbecco's modified Eagle's
medium (DMEM; LGC, Cotia, Brazil) supplemented with
10% fetal bovine serum (FBS; Cultlab, Campinas, Brazil),
100 U/ml penicillin and 100 μg/ml streptomycin. The cul-
tures were maintained at 37°C in a humid atmosphere
with 5% carbon dioxide, and the medium was changed
every 3 to 5 days until the cell monolayer reached conflu-
ence. At confluence, the cells were harvested with 0.125%
trypsin (Gibco, Rockville, MD, USA) and 0.78 mM ethyl-
enediamine tetraacetic acid (Gibco). After harvesting with
trypsin, the cells were analyzed by flow cytometry or
replated for lipid accumulation and secretory analyses.
Flow cytometry assay
The cells isolated from the adipose tissue of the obese
(n = 12), postbariatric surgery ex-obese (n = 7) and con-
trol (n = 6) patients were monitored by flow cytometry
for surface marker expression at the moment they were
isolated (SVF) and after culture (ASCs). The cell sus-
pensions were washed with phosphate-buffered saline
containing 3% bovine serum albumin and incubated for
30 minutes at 4°C with monoclonal antibodies conjugated
with fluorescent dyes: CD45–fluorescein isothiocyanate,
CD31–phycoerythrin (PE), CD146–PE, CD14–PE, CD34–
PE-cyanin 5, CD206–PE-cyanin 5, CD73–peridin chloro-
phyll and/or CD90–PE (all from BD Biosciences, Franklin
Lakes, NJ, USA). Subsequently, the cells were washed
with phosphate-buffered saline containing 3% bovine
serum albumin. Incubation with FACS lysing solution (BD
Biosciences) at room temperature in the absence of light
for 10 minutes and with 7-actinomycin D (BD Biosciences)
was performed on the SVF cell suspensions. The cellsthat were stained with a single antibody coupled with a
fluorescent dye (fluorescein isothiocyanate, PE, or PE-
cyanin 5) were acquired for compensation purposes.
For each tube, 100,000 and 20,000 events of SVF and
ASC samples, respectively, were acquired in a FACS
Calibur (BD Biosciences). The flow cytometry analyses
were performed using the software FACS Diva 8.0 (BD
Biosciences, Franklin Lakes, NJ, USA). On fresh samples
from the morbid obese, postbariatric surgery ex-obese and
control patients, a gate was set to include only viable cells
(7-actinomycin D negative cells). Pericytes, supra-adventitial
and endothelial progenitor cells were identified according
to Zimmerlin and colleagues [12]. Resident adipose tissue
macrophages were identified among the hematopoietic
cells (CD45) by the expression of CD14 and CD206
(mannose receptor) [16]. Cell quantification was expressed
as the absolute number of cells per gram of processed
adipose tissue.
In the culture-expanded cells (ASCs), the expression
of CD34, CD73 and CD90 was given as a percentage of
positive cells among the 20,000 events acquired for each
sample (n = 3 for each group).
Lipid accumulation stimulus
Induction lipid accumulation was performed by seeding
2 × 104 ASCs in each well of a 48-well plate (in triplicate),
cultured with inductive media for up to 6 weeks; the
medium consisted of DMEM with 10% FBS, 10 μM insulin,
0.5 mM isobutylmethylxanthine, 1 μM dexamethasone,
and 200 μM indomethacin (Sigma). After 3 weeks of in-
duction, the cells were maintained in 0.220 ml/well DMEM
with 2% FBS and incubated for 24 hours. After this period,
the supernatant was collected and frozen at –80°C, and the
monolayer was fixed in 10% buffered formaldehyde for 60
minutes. Lipid accumulation was assessed using Oil Red O
staining (Sigma), adipose differentiation-related protein
(ADRP) and perilipin detection.
Oil red O staining
After the induction to lipid accumulation, the fixed cells
were stained with 5 mg/ml Oil Red O in 70% ethanol for 1
hour. Overstaining was washed with buffered phosphate sa-
line. The stain was dissolved for 10 minutes with isopropa-
nol, and the absorbance of the eluted stain was measured
in a spectrophotometer at 490 nm. The absorbance of the
induced cultures was subtracted from the values obtained
with the noninduced cultures. Three replicates for each pa-
tient condition (obese, postbariatric surgery ex-obese and
control) in five independent experiments were analyzed.
Immunofluorescence for adipose differentiation-related
protein and perilipin
After the induction to lipid accumulation, the fixed cells
were permeabilized with 0.2% Triton X-100 (Merck
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with 0.2% monkey serum for 20 minutes to prevent the
nonspecific binding of immunoglobulins. An overnight
incubation at 4°C was performed with anti-ADRP
(1:1,200; Fitzgerald, Acton, MA, USA) and anti-perilipin
(1:500; Biorbyt, Cambridge, UK). For the anti-ADRP and
anti-perilipin primary antibodies, the secondary antibody
staining was performed using Alexa 488-conjugated
anti-monkey IgG (Fitzgerald) and cyanin 3-conjugated
anti-rabbit (Fitzgerald), respectively, for 1 hour at room
temperature. The slides were mounted in a commercial
Fluoromount Mounting Medium that contained 4′,6-
diamidino-2-phenylindole for nuclear detection (Sigma)
and were examined using fluorescence microscopy
followed by deconvolution (Olympus, Shinjuku, Tóquio,
Japão). The samples incubated without the primary
antibodies but with the secondary antibodies were used
as the negative controls.
Cytokine secretion of adipose stem cells
To evaluate cytokine secretion by unstimulated ASCs,
the cells were seeded in a 48-well plate (in triplicate, 2 ×
104 ASCs in each well) and incubated for 24 hours in
DMEM with 2% FBS. To evaluate how the cells
responded to a proinflammatory stimulus, 0.5 μg/ml
lipopolysaccharide (LPS) was added to the incubating
medium. After 3 weeks of adipogenic induction, the adi-
pogenic induced ASCs (in triplicate) were also incubated
for 24 hours in DMEM with 2% FBS. After the incuba-
tion period, the supernatant of each replicate was col-
lected individually and frozen at −80°C.
The release of cytokines, chemokines and growth fac-
tors in the conditioned medium of the unstimulated,
LPS-stimulated and adipogenic induced cells was mea-
sured using two multiplex immunoassay detection sys-
tems capable of analyzing levels of Bio-PlexPro™ human
cytokine 17-plex and levels of Human Adipocyte Panel
(Merck Millipore) according to the manufacturer’s rec-
ommendations. Three replicates for each patient condi-
tion (obese, postbariatric surgery ex-obese and control)
in three independent experiments were analyzed.
Statistical analysis
A nonparametric one-way analysis of variance test
followed by Dunn’s test was used for comparisons
among the control, obese and postbariatric surgery ex-
obese patients in the flow cytometry, adipogenic and
cytokine secretion assays. Student’s t test was used to
compare LPS treatment or adipogenic induced cells with
unstimulated cells. The results in the graphs are
expressed as the mean ± standard error of the mean, and
P <0.05 was considered statistically significant. The ana-
lyses were performed using the software GraphPad
Prism 5.0 (GraphPad Software, San Diego, CA, USA).Results
The stromal vascular fraction of obese and postbariatric
surgery ex-obese patients was enriched with pericytes
and supra-adventitial cells
To evaluate how obesity and weight loss may affect the
distribution of SVF subpopulations in subcutaneous adi-
pose tissue, independent samples from obese, postbaria-
tric surgery ex-obese and control patients were analyzed
by flow cytometry. A representative sample of each con-
dition is shown in Figure 1. 7-Actinomycin D staining
distinguishes nonviable cells present in adipose tissue di-
gests (Figure 1A). The viable cells (negative for 7-
actinomycin D) were analyzed for the presence of the
classifying markers (CD45, CD146, CD34, CD31, CD14
and CD206) described previously [12,16]. Hematopoietic
and nonhematopoietic cells were identified according to
the expression of the panhematopoietic marker CD45
(Figure 1E,I,M). The nonhematopoietic cells (CD45neg)
contained supra-adventitial cells (CD34posCD31neg;
Figure 1E,J,N), endothelial progenitor cells (CD34posCD31neg;
Figure 1E,J,N) and pericytes (CD146posCD34neg;
Figure 1G,K,M).
Subsequently, we analyzed the mono-macrophage
CD14pos populations among the hematopoietic cells, ac-
cording to the expression of CD206 (Figure 1H,L,P).
Two mono-macrophage subpopulations were identified:
CD14posCD206pos cells, called alternatively activated
(M2) macrophages; and CD14posCD206neg cells, which
include classically activated macrophages (M1).
Pericytes were most prevalent in the obese patients;
additionally, the postbariatric surgery ex-obese patients
presented a higher number of pericytes per gram of adi-
pose tissue than the controls (Figure 2A). Interestingly,
the adipose tissue from the postbariatric surgery ex-
obese patients was the most enriched with supra-
adventitial cells (Figure 2B). No significant changes were
identified for endothelial progenitor cells (Figure 2C).
The CD45posCD14posCD206neg population, which con-
tains M1 macrophages, was clearly enriched in the obese
patients and returned to normal levels after massive weight
loss (Figure 2D). No statistically significant difference was
observed in the M2 macrophage content (Figure 2E). The
proportion of the two macrophage subpopulations (M1
and M2) was similar in the obese adipose tissue, whereas
M2 macrophages were predominant in the control and
postbariatric surgery ex-obese patients (Figure 2F). How-
ever, the postbariatric surgery ex-obese adipose tissue
showed a slight increase in the absolute number concomi-
tant to a predominance of M2 (Figure 2E,F).
Obesity alters ASC cytokine secretion profiles, which are
not completely restored after massive weight loss
After in vitro cultivation, the ASCs from the subcutane-
ous fragments of the obese, postbariatric surgery ex-
Figure 1 (See legend on next page.)
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Figure 1 Classification of perivascular and hematopoietic populations for analytical flow cytometry. Stromal vascular fraction (SVF) of adipose
tissue from the control, obese and postbariatric surgery ex-obese patients were analyzed by flow cytometry. The viable cells identified by 7-actinomycin
D (7AAD) exclusion (A) were first analyzed according to CD45 expression (E, I, M). The gates were set on nonhematopoietic (CD45neg; NHe) and
hematopoietic (CD45pos; He) cells. The CD45neg cells (red) were further analyzed for CD34 and CD31 expression (F, J, N) or CD34 and CD146 expression
(G, K, O). A green gate was set to identify the subset of supra-adventitial cells (SA), which were CD34posCD31neg, whereas the endothelial progenitor cells
(EP) were identified as CD34posCD31pos (purple gate). A blue gate was set on the CD146posCD34neg cells to identify the pericytes. The mono-macrophage
cells were analyzed among the He cells (H, L, P). Adipose tissue resident macrophages were identified as CD14posCD206pos cells (upper right
quadrant). A population of CD14posCD206neg was also identified (lower right quadrant). (B, C, D) Compensation controls of fluorescence
detection. Ctr, control; EP, endothelial progenitor cell; ExOB, postbariatric surgery ex-obese; FITC, fluorescein isothiocyanate; M1rich, enriched
in M1 (classically activated) macrophages; M2, alternatively activated macrophages; OB, obese; PC, pericytes; PE, phycoerythrin; PECy5, PE-cyanin 5;
SA, supra-adventitial cells.
Figure 2 Different stromal vascular fraction contents of adipose tissue from obese, postbariatric surgery ex-obese and control patients. Quantitative
data for the flow cytometry analysis show the different distributions of the nonhematopoietic (A, B, C) and hematopoietic (D, E) cell subsets. The
number of cells per adipose tissue (AT) gram from each subpopulation analyzed is expressed as the mean ± standard error of the mean. (F) The ratio
of CD206− and CD206+ cells is expressed. Analysis of variance tests comparing the cell numbers were performed. P values from the statistical tests:
*P <0.05. Ctr, control; ExOB, postbariatric surgery ex-obese; M1rich, enriched in M1 (classically activated) macrophages; M2, alternatively activated
macrophages; OB, obese; SVF, stromal vascular fraction.
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morphology (Figure 3A,B,C). A flow cytometry analysis
of ASCs at passage 1 for the supra-adventitial/preadipo-
cyte marker CD34 (Figure 3D,E,F) and for the in vitro
mesenchymal markers CD73 (Figure 3G,H,I) and CD90
(Figure 3J,K,L) revealed differences only concerning CD34
expression. The quantitative data from the flow cytom-
etry analyses (Table 1) showed that the ASCs from the
obese patients had the lowest number of CD34poscells
whereas this value was similar in postbariatric surgery
ex-obese and control patients. As expected, the ASCs
from all conditions at passage 3 showed a more homoge-
neous population (Figure 3M to U). All of the following ex-
periments were performed using the cells at passage 3.
We also hypothesized that obesity and massive weight
loss could modify ASCs in terms of cytokine secretion,
which could represent different paracrine properties.
Highly confluent cultures of ASCs were maintained for
24 hours under standard cell culture conditions (control)
or LPS stimulation to simulate a proinflammatory stimulus.
The quantitative data for cytokine secretion on the super-
natant are expressed in Figure 4. Under control conditions,
the ASCs from all groups secreted IL-6, IL-8, macrophage
chemoattractive protein-1 (MCP-1; Figure 4A,C,E) and
Plasminogen activator inhibitor-1 (data not shown). The
ASCs from the morbid obese patients secreted more proin-
flammatory cytokines such as IL-6 (Figure 4A) and IL-8
(Figure 4E) than the control ASCs. The postbariatricFigure 3 Phenotypical characterization of adipose stem cells from the contro
stem cells (ASCs) from the subcutaneous adipose tissue of patients for all
magnification). Histograms show the ASC surface expression of CD34 (D,
the cells cultivated at passage 1 (D to L) and expanded up to passage 3
obese (E, H, K, N, Q, T) and postbariatric surgery ex-obese (F, I, L, O, R,
Gray histogram, negative control; red histogram, expression at passage 1; blu
in Table 1. P values from the analysis of variance tests comparing percentage
OB, obese; PE, phycoerythrin; PECy5, PE-cyanin 5; PERCP, peridin chlorophyll.surgery ex-obese patients showed a 3.7-fold greater secre-
tion of MCP-1 compared with the controls. Under proin-
flammatory stimulation with LPS, the ASCs from all
conditions responded by enhancing cytokine secretion of
IL-6, IL-8 and MCP-1 (Figure 4B,D,F).
Obesity decreases ASC lipid accumulation capacity and
adiponectin secreted levels
The ability of ASCs to accumulate lipids in vitro was
evaluated among the studied groups. The ASCs from
obese patients showed the lowest lipid accumulation
capacity (Figure 5A,B,C,D). The quantitative data for the
total amount of Oil Red O stain captured by lipid droplets
are expressed in Figure 5D. Qualitatively, the lipid droplets
of cells from the postbariatric surgery ex-obese patients
showed a prevalence of perilipin staining (Figure 5G),
which is typical of adipocyte maturation [30], whereas
those from the obese patients’ ASCs showed a prevalence
of ADRP (Figure 5F), which is usually found in earlier
phases of adipogenesis [30].
The cytokine secretion profile was also evaluated after
3 weeks of in vitro adipogenic stimulus (Figure 5H,I,J,K).
The ASCs showing lipid accumulation secreted less IL-6
(Figure 5H) than the corresponding ASCs with no lipid
accumulation (Figure 4A), as described recently [31]. In
addition, higher amounts of IL-6 (Figure 5H) and IL-8
(Figure 5J) were secreted by lipid accumulation-stimulated
obese ASCs than by the control and postbariatric surgeryl, obese and postbariatric surgery ex-obese patients. Adipose stromal/
conditions showed fibroblastoid cells (A, B, C, phase contrast, 100×
E, F, M, N, O), CD73 (G, H, I, P, Q, R) and CD90 (J, K, L, S, T, U) of
(M to U). Histograms of the ASCs from the control (D, G, J, M, P, S),
U) samples are representative of three independent experiments.
e histogram, expression at passage 3. Quantitative results are summarized
numbers: *P = 0.038. Ctr, control; ExOB, postbariatric surgery ex-obese;
Table 1 Quantification of CD34, CD73 and CD90 expression by adipose stem cells
CD45–CD34+ (%) CD45–CD73+ (%) CD45–CD90+ (%)
Passage 1a Passage 3 Passage 1 Passage 3 Passage 1 Passage 3
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
ASC Ctr 82 ±9.9 1.4 ±2.5 83.4 ±11.9 93.9 ±2.6 88 ±10.2 96.5 ±1.6
ASC OB 62.01 ±15.5 0 ±0 87.3 ±2.1 93.1 ±1.3 92.3 ±2.76 97.8 ±0.3
ASC ExOB 85.2 ±3.1 1.1 ±1.9 95 ±2.8 94.1 ±1.5 96.2 ±1.2 96.8 ±1.7
ASC, adipose stem cell; Ctr, control; ExOB, postbariatric surgery ex-obese; OB, obese; SD, standard deviation. aAnalysis of variance: P = 0.038.
Silva et al. Stem Cell Research & Therapy  (2015) 6:72 Page 8 of 13ex-obese ASCs. Interestingly, MCP-1 secretion was the
highest in the ASCs with lipid accumulation derived from
the control patients (Figure 5I). In patients of all condi-
tions, the secretion of the anti-inflammatory cytokine adi-
ponectin was only detected in cells after an adipogenic
stimulus. The ASCs showing lipid accumulation of the
control showed the highest adiponectin secretion, whereas
the postbariatric surgery ex-obese samples had lower adi-
ponectin secretion, and the obese samples had the lowest
secretion levels (Figure 5K).
Discussion
Herein we show that SVF content and ASC behavior
in vitro are altered in severely obese women. In addition,
massive weight loss induced by treatment with bariatric
surgery does not recover the normal cell physiology of
ASCs in terms of adipogenesis and cytokine secretion.
A flow cytometry analysis performed in freshly isolated
cells revealed that obese and ex-obese subcutaneous fat
contains an increased number of pericytes. These results
may be related to changes in the blood vessels’ content
that occurs during obesity [32-34]. A higher frequency
of pericytes was found in the ex-obese patients com-
pared with the control patients; this result is consistent
with our previous study, which described that the num-
ber of small vessels is up to twofold times higher com-
pared with the control patients [20]. Furthermore, there
was also increasing evidence for the key role of stem
cells in obesity [35]. In a mouse model, tumor necrosis
factor alpha, which is highly produced in obese adipose
tissue, contributes to the recruitment of both macro-
phages [9] and stem cells [36]. CD146, a pericyte surface
marker, is involved in monocyte transendothelial migra-
tion during inflammation [37]. The higher frequency of
pericytes in obese adipose tissue may therefore result
from a cytokine-mediated mobilization of these cells,
representing a source of cells available for tissue growth,
repair and wound healing.
According to the overflow hypothesis described by Berg-
man and coworkers [38], the visceral fat compartment in-
creases primarily with moderate fat intake. However, as fat
feeding increases, both visceral and subcutaneous fat en-
largement occurs. We could presume that this subcutane-
ous fat tissue enlargement could be because of an increasein the number of pericytes, which are able to generate
new preadipocytes [32] that are capable of storing lipids
and meeting the amount of fat intake.
We found that the ex-obese patients had fourfold
more supra-adventitial cells than the obese patients. Be-
cause adipocytes are able to dedifferentiate [39], it could
be assumed that during massive weight loss the adipo-
cytes dedifferentiated into supra-adventitial cells because
these cells have preadipocyte characteristics [12]. This
result was also consistent with our previous study of
postbariatric surgery ex-obese subcutaneous fat, showing
that the area occupied by robust blood vessels with an
adventitial layer is up to two times larger than the con-
trol area [20].
Adult stem cells from subcutaneous adipose tissue are
in fact regenerative cells with wide use in medicine re-
generative approaches. Within the SVF, regenerative
cells include pericytes and supra-adventitial cells. Be-
cause of the ease of subcutaneous harvesting and the
possibility of SVF isolation in the operating room, a var-
iety of clinical trials uses SVF [17,18]. The enrichment of
pericytes and supra-adventitial cells found in obese and
postbariatric surgery ex-obese adipose tissues, respect-
ively, could have an unknown effect on the regenerative
effects of the SVF.
We analyzed mono-macrophage CD14pos populations
among hematopoietic cells according to the expression
of CD206 (Figure 1H,L,P). Two mono-macrophage sub-
populations were identified: CD14posCD206pos cells,
called alternatively activated (M2) macrophages; and
CD14posCD206neg cells, which include classically acti-
vated macrophages (M1). Because of the lack of an ap-
propriate marker that identifies exclusively human M1
macrophages, we could not quantify this population, but
the CD45posCD14posCD206neg population, which con-
tains M1 macrophages, is clearly enriched in obese pa-
tients, as expected [40,41], and returns to normal levels
after massive weight loss (Figure 2D). M1 macrophages
recruited to the SVF during obesity development are
known to secrete proinflammatory cytokines [9,14], in
contrast to the anti-inflammatory state found in M2
resident adipose tissue macrophages. It was recently ob-
served that M2 macrophages were increased in animals
during weight loss [42]. In addition, an increase in M2
Figure 4 Differential cytokine secretion of adipose stem cells isolated from patients with different conditions. Cytokine secretion in the supernatant of
cells cultivated under control conditions (A, C, F) and under lipopolysaccharide (LPS) stimuli (B, D, F) was evaluated using a multiplex assay. The
graphs show data from one representative experiment of three independent experiments. P values obtained after the analysis of variance (ANOVA)
tests are indicated under each graph. Solid and dotted lines indicate the statistical results of the ANOVA post test and the t test, respectively. P values
from the statistical tests: *P <0.05, **P <0.001. Ctr, control; ExOB, postbariatric surgery ex-obese; IL, interleukin; MCP-1, macrophage chemoattractive
protein-1; OB, obese.
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Figure 5 Differential lipid accumulation capacity and cytokine secretion of induced adipose stem cells from obese, postbariatric surgery ex-obese
and control patients. The adipose stem cells (ASCs) were cultured under inductive medium to accumulate lipids for up to 3 weeks, after which
lipid accumulation was accompanied by Oil Red O staining (A, B, C) or by staining with perilipin and adipose differentiation-related protein (E, F, G).
The total Oil Red O dye captured by the lipid droplets was measured in a spectrophotometer. (D) Representative data from five independent
experiments, expressed as the mean ± standard error of the mean, which represents the quantitative results of the Oil Red O staining. Analysis
of variance (ANOVA) tests comparing the absorbances were performed (P <0.0001). The supernatant of the induced cells was evaluated for
cytokine secretion. (H) Interleukin (IL)-6, (I) macrophage chemoattractive protein-1 (MCP-1), (J) IL-8 and (K) adiponectin. ANOVA tests comparing the
secretions were performed. P values from the statistical tests: **P <0.001, ***P <0.0001. (A, B, C) Optical microscopy, bar size: 50 μm. (D, E, F)
Fluorescence laser confocal microscopy, bar size = 20 μm. Ctr, control; ExOB, postbariatric surgery ex-obese; OB, obese.
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after gastric surgery was reported [41]. Macrophages
with M2 characteristics can play an essential role in tis-
sue homeostasis by preventing inflammation and pro-
moting insulin sensitivity. Our results show that this
increase may be persistent because the analyses were
performed at least 2 years after bariatric surgery.Some studies have investigated the cytokine secre-
tion of ASCs isolated from human subcutaneous adi-
pose tissue with different adiposity grades [10,31,43]
such as obese and nonobese individuals. An upregula-
tion of inflammatory genes in ASCs isolated from
obese subcutaneous adipose tissue has been reported
[44]. Accordingly, we found that ASCs from the
Silva et al. Stem Cell Research & Therapy  (2015) 6:72 Page 11 of 13morbid obese patients secreted more proinflammatory
cytokines such as IL-6 and IL-8.
MCP-1 was highly secreted by the postbariatric sur-
gery ex-obese ASCs, and we observed no differences be-
tween the control and obese patients. It is well
established that macrophages are able to secrete MCP-1,
resulting in macrophage mobilization. Recently, Cancello
and colleagues demonstrated that the gene expression of
human subcutaneous adipose tissue is not fully restored
after massive and stable weight loss, suggesting a persist-
ence of obesity molecular characteristics [45]. We can
thus postulate that in vivo counterparts of postbariatric
surgery ex-obese ASCs could also contribute to macro-
phage recruitment.
The secretion of these cytokines was further upregu-
lated after incubation with a proinflammatory stimulus
(LPS). Lee and colleagues showed that tumor necrosis
factor alpha induction augmented the secretion of IL-6,
IL-8 and MCP-1 of ASCs [43]. In addition, it was dem-
onstrated that LPS also induced ASCs to secrete IL-6,
IL-8 and tumor necrosis factor alpha [46], indicating
that ASCs are responsive to proinflammatory stimuli by
secreting proinflammatory cytokines.
Indeed, it was observed that ASC function is altered
when the disruption of tissue homeostasis occurs, such
as in diabetes [26-28]. The alterations in ASC function
observed in the present study may therefore be a result
of the homeostasis disruption found in the obesity in-
flammatory scenario.
In our previous study, ASCs isolated from postbaria-
tric surgery ex-obese patients had an accelerated lipid
accumulation under an adipogenic stimulus compared
with the controls [20]. However, in this study, the ASCs
from obese patients showed the lowest lipid accumula-
tion capacity. Some studies have shown an inverse cor-
relation between BMI and lipid accumulation capacity.
In addition, obesity reduces the differentiation capacity
of the adipose ASCs [44-48], and it has been recently
proposed that the inflammatory state could be responsible
for impaired adipocyte differentiation [49]. Recently, Oñate
and colleagues have shown an upregulation of inflamma-
tory genes coinciding with a reduction of stemcellness of
obese ASCs [44]. The prevalence of lipid droplets with
perilipin expression observed in postbariatric surgery
ex-obese cells confirms a precommitment of ASCs with
the adipogenic lineage.
Proinflammatory cytokines secreted by macrophages
in the adipose tissue during obesity development are
known to inhibit the adipogenesis of adipocyte precursor
cells in vitro [50,51]. A recent study showed that obesity
modifies ASC plasticity to differentiate towards adipo-
genic and osteo-chondrophenotypes in mice [52]. Con-
sidering that in vitro cultivated ASCs are continuously
attracting the attention of clinicians because of theirtherapeutic potential for regenerative medicine, cell ther-
apy and tissue engineering, it is necessary to better
understand the mechanisms by which the differentiation
capacity of ASCs are altered in obesity.
Otherwise, the higher lipid accumulation observed in
the ASCs of postbariatric surgery ex-obese patients
could be explained by the high content of supra-
adventitial cells in the SVF, which was observed by flow
cytometry. An adipogenic commitment on the SVF
along with an altered vascular tree on the adipose tissue
of postbariatric surgery ex-obese patients [20] may favor
the weight regain and possibly a return to the obese
state. Further investigations based on cell sorting of
supra-adventitial populations will clarify their patho-
physiological contributions.
Adiponectin is an anti-inflammatory cytokine, and its
production by adipose tissue is inversely correlated to
BMI [53]. Although the control and postbariatric surgery
ex-obese patients from the present study had similar
BMI levels, ASCs from the postbariatric surgery ex-
obese patients showing lipid accumulation had secreted
lower levels of adiponectin, reinforcing the fact that
postbariatric surgery ex-obese tissues do not restore adi-
pose tissues to the normal scenario.
The cohort of patients included in this study may not
necessarily represent the general population in terms of
adiposity and socioeconomic characteristics, which may
limit the application of our study to the general popula-
tion. Such subgroup selections should be taken into con-
sideration when comparing our results with other
studies because they introduce the potential for bias and
confounding.
Conclusions
Herein, we show that obesity is responsible for an al-
tered subcutaneous adipose tissue SVF composition and
ASC behavior in vitro. Furthermore, massive weight loss
induced by treatment with bariatric surgery does not re-
cover the normal cell physiology of ASCs in terms of
lipid accumulation and cytokine secretion. These alter-
ations could affect regenerative effects when using these
cells as tools for regenerative medicine. Further molecu-
lar investigations after the cell sorting of pericytes and
supra-adventitial cells are required to progress our
knowledge of obese and postbariatric surgery ex-obese
subcutaneous adipose tissues to avoid jeopardizing the
development of autologous stem cell-based therapies.
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